0001127602-17-001449.txt : 20170110
0001127602-17-001449.hdr.sgml : 20170110
20170110170827
ACCESSION NUMBER: 0001127602-17-001449
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170109
FILED AS OF DATE: 20170110
DATE AS OF CHANGE: 20170110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stejbach Mark
CENTRAL INDEX KEY: 0001487937
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 17521249
MAIL ADDRESS:
STREET 1: C/O TENGION, INC.
STREET 2: 2900 POTSHOP LANE, SUITE 100
CITY: EAST NORRITON
STATE: PA
ZIP: 19403
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-01-09
0001520262
Alkermes plc.
ALKS
0001487937
Stejbach Mark
852 WINTER ST.
WALTHAM
MA
02451
1
SVP/Chief Comm Off, Alks Inc
Ordinary Shares
2017-01-09
4
M
0
547
17.30
A
34662
D
Ordinary Shares
2017-01-09
4
S
0
547
60.27
D
34115
D
Employee Stock Option (Right to Buy)
17.30
2017-01-09
4
M
0
547
0
D
2022-03-07
Ordinary Shares
547
26660
D
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
These options are fully vested in accordance with their terms.
/s/ Jennifer Baptiste, attorney-in-fact for Mark Stejbach
2017-01-10